RPS6P15

Across TCGA pan-cancer cohorts, RPS6P15 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPS6P15 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS6P15 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPS6P15 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

BLCA, MESO, and KIRP are the cancer types where RPS6P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	1.000	0.286	.009	57	view →
MESO	DFS	Tertile	All	0.182	0.393	.001	45	view →
KIRP	OS	Tertile	II,III,IV	0.143	0.748	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.552	0.337	.006	31	view →
SKCM	DFS	Tertile	II,III,IV	0.410	0.588	.006	21	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.798	.016	18	view →
TGCT	OS	Tertile	II,III,IV	0.795	1.000	.039	18	view →
CESC	OS	Tertile	IV	0.355	0.632	.030	18	view →
PCPG	DFS	Quartile	All	0.754	0.931	.002	16	view →
ACC	DFS	Median	III,IV	0.844	0.298	.011	10	view →
LGG	OS	Tertile	All	0.970	0.884	.012	9	view →
GBM	OS	Tertile	All	0.299	0.557	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPS6P15–BLCA (DFS)

Open the BLCA breakdown →